tiprankstipranks
Advertisement
Advertisement

ZLDPF Stock Latest News

Zealand Pharma price target lowered to DKK 435 from DKK 460 at JPMorgan
The FlyZealand Pharma price target lowered to DKK 435 from DKK 460 at JPMorgan
4d ago
Zealand Pharma enters $100M royalty purchase, sale pact with Royalty Pharma
PremiumThe Fly
Zealand Pharma enters $100M royalty purchase, sale pact with Royalty Pharma
12d ago
RPRX
Zealand Pharma price target raised to DKK 420 from DKK 410 at Wells Fargo
PremiumThe Fly
Zealand Pharma price target raised to DKK 420 from DKK 410 at Wells Fargo
13d ago
ZLDPF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ZLDPF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
18d ago
Zealand Pharma’s Dasiglucagon Study Moves Forward in Rare Childhood Disease
PremiumCompany Announcements
Zealand Pharma’s Dasiglucagon Study Moves Forward in Rare Childhood Disease
26d ago
ZLDPF
Zealand Pharma’s New Psoriasis Trial Sets Early Stage for ZP9830
PremiumCompany AnnouncementsZealand Pharma’s New Psoriasis Trial Sets Early Stage for ZP9830
1M ago
ZLDPF
Zealand Pharma Advances First-in-Human Obesity Drug Trial With ZP6590
Premium
Company Announcements
Zealand Pharma Advances First-in-Human Obesity Drug Trial With ZP6590
1M ago
ZLDPF
Zealand Pharma downgraded to Hold from Buy at Jefferies
Premium
The Fly
Zealand Pharma downgraded to Hold from Buy at Jefferies
2M ago
Zealand Pharma downgraded to Hold from Buy at Berenberg
PremiumThe Fly
Zealand Pharma downgraded to Hold from Buy at Berenberg
2M ago
Roche and Zealand Advance Combo Obesity Drug Trial, Signaling New Momentum for ZLDPF
PremiumCompany Announcements
Roche and Zealand Advance Combo Obesity Drug Trial, Signaling New Momentum for ZLDPF
3M ago
ZLDPF
Zealand Pharma announces Boehringer’s phase III results of survodutide
PremiumThe Fly
Zealand Pharma announces Boehringer’s phase III results of survodutide
3M ago
Zealand Pharma presents additional data from ZUPREME-1 trial
PremiumThe Fly
Zealand Pharma presents additional data from ZUPREME-1 trial
3M ago
Zealand Pharma price target raised to DKK 300 from DKK 275 at Deutsche Bank
PremiumThe FlyZealand Pharma price target raised to DKK 300 from DKK 275 at Deutsche Bank
3M ago
Zealand Pharma upgraded to Buy from Hold at SEB Equities
Premium
The Fly
Zealand Pharma upgraded to Buy from Hold at SEB Equities
4M ago
Zealand Pharma, Roche to advance petrelintide for weight management to Phase 3
Premium
The Fly
Zealand Pharma, Roche to advance petrelintide for weight management to Phase 3
4M ago
CHRO
Zealand Pharma appoints Eric Rojas as VP, head of IR
PremiumThe Fly
Zealand Pharma appoints Eric Rojas as VP, head of IR
5M ago
Zealand Pharma Advances Obesity Pipeline With Completed Petrelintide Dose Study
PremiumCompany Announcements
Zealand Pharma Advances Obesity Pipeline With Completed Petrelintide Dose Study
5M ago
ZLDPF
Zealand Pharma establishes U.S. research hub in Cambridge, Massachusetts
PremiumThe Fly
Zealand Pharma establishes U.S. research hub in Cambridge, Massachusetts
5M ago
Zealand Pharma price target lowered to DKK 275 from DKK 450 at Deutsche Bank
PremiumThe Fly
Zealand Pharma price target lowered to DKK 275 from DKK 450 at Deutsche Bank
6M ago
Zealand Pharma price target lowered to DKK 460 from DKK 1,000 at JPMorgan
PremiumThe FlyZealand Pharma price target lowered to DKK 460 from DKK 1,000 at JPMorgan
6M ago
Zealand Pharma downgraded to Neutral from Outperform at BNP Paribas
Premium
The Fly
Zealand Pharma downgraded to Neutral from Outperform at BNP Paribas
6M ago
Zealand Pharma downgraded to Market Perform from Outperform at William Blair
Premium
The Fly
Zealand Pharma downgraded to Market Perform from Outperform at William Blair
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >